# Evoralis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evoralis

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.evoralis.com/
- Total disclosed funding: $3.2M
- Latest round: Seed (Jul 30, 2024)
- Investors on record: 6

## About

Founded in 2021 and based in Cambridge, UK, Evoralis Limited a spin out from the University of Cambridge, operates as a biotechnological company that develops plastic recycling solutions. In September 2024, Evoralis Limited raised GBP 2.5 million in seed funding led by investor LIFTT, with participation from other investors Archipelago Ventures, BackBone Ventures, Cambridge Enterprise, CPI, and Parkwalk Advisors. The firm as of September 2024, is led by its co-founders, Daniel Kaute (CEO), Josephin Holstein (CTO), and Mariana Rangel Pereira (CSO).

Evoralis Limited focuses on plastic recycling through enzyme development. The company creates biocatalysts that break down various plastics, such as polyester, nylon, and elastane, transforming them into quality raw materials. Its patent-pending microfluidic ultra-high-throughput screening platform enables rapid discovery (by up to 1,000 times compared to traditional methods) and optimization of tailored enzymes, including those suited for contaminated plastics. Evoralis serves multiple industries, including fashion, automotive, and packaging, providing enzyme sales, technology licensing, and fee-for-service applications to enhance recycling processes.

## Funding rounds

- Seed, Jul 30, 2024, $3.2M — Cambridge Enterprise, Parkwalk Advisors, BackBone Ventures, LIFTT, CPI, Archipelago Ventures

## Investors

- Cambridge Enterprise — Seed
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Seed
- BackBone Ventures (https://capitalatlas.ai/funds/backbone-ventures) — Seed
- LIFTT (https://capitalatlas.ai/funds/liftt) — Seed
- CPI — Seed
- Archipelago Ventures — Seed